Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Clinical Study of KW-3357 in Patients Diagnosed as Disseminated Intravascular Coagulation (DIC) by Japanese Association for Acute Medicine-defined DIC Criteria.

Trial Profile

A Clinical Study of KW-3357 in Patients Diagnosed as Disseminated Intravascular Coagulation (DIC) by Japanese Association for Acute Medicine-defined DIC Criteria.

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 11 Jul 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Antithrombin gamma (Primary)
  • Indications Disseminated intravascular coagulation
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Kyowa Kirin
  • Most Recent Events

    • 03 Jul 2015 According to Kyowa Hakko Kirin media release, KW 3357 (ACOALAN) has been approved by the Misnistry of Health, Labour and Welfare of Japan.
    • 01 Aug 2014 Kyowa Hakko Kirin has submitted an application for approval in Japan for KW 3357, based on results from this trial and two other phase III trials, according to a Kyowa Hakko Kirin media release.
    • 24 Apr 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top